Watch PRAX. Know when insiders buy.
One email the day a filing lands. Free.
PRAX
Praxis Precision Medicines, Inc.
258.92
+2.45 +0.96%
USD · close Oct 22
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
48
WATCH · shorts 48
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
2 / 0
buys / sells · latest disclosed Oct 12
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $7.2BP/E —DIV YIELD —FCF YIELD -4.22%REV TTM —NET INCOME −$339.1MNET CASH —52W 164.09 – 386.33SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$96.9M | −$83.7M | — | -2.87 | −$77.5M | $245K | −$77.8M | Aug 6 |
| Q1 2026 · Mar 31 | — | — | — | −$105.9M | −$92.6M | — | -3.20 | −$86.2M | $62K | −$86.2M | Aug 6 |
| Q4 2025 · Dec 31derived | $0 | −100.0% | — | −$97M | −$88.9M | — | -3.51 | −$76.3M | $0 | −$76.3M | Feb 19 |
| Q3 2025 · Sep 30 | $0 | −100.0% | — | −$78.4M | −$73.9M | — | -3.36 | −$65.1M | $0 | −$65.1M | Nov 5 |
| Q2 2025 · Jun 30 | $0 | −100.0% | — | −$76.1M | −$71.1M | — | -3.31 | −$54.7M | $56K | −$54.7M | Aug 6 |
| Q1 2025 · Mar 31 | $0 | −100.0% | — | −$74.7M | −$69.3M | — | -3.29 | −$53M | $0 | −$53M | Aug 6 |
| Q4 2024 · Dec 31 | $7.5M | +1349.1% | — | −$64M | −$58.7M | — | -3.00 | −$56.1M | $0 | −$56.1M | Feb 19 |
| Q3 2024 · Sep 30 | $302K | −35.5% | — | −$56.8M | −$51.9M | — | -2.75 | −$27.5M | $0 | −$27.5M | Nov 5 |
| Q2 2024 · Jun 30 | $357K | — | — | −$37.5M | −$32.7M | — | -1.74 | −$27.3M | — | — | Nov 5 |
| Q1 2024 · Mar 31 | $431K | — | — | −$41.9M | −$39.6M | — | -2.84 | −$20.9M | — | — | Nov 5 |
| Q4 2023 · Dec 31 | $515K | — | — | −$27.8M | −$26.9M | — | -1.96 | −$23.9M | $50K | −$23.9M | Feb 19 |
| Q3 2023 · Sep 30 | $468K | — | — | −$25.5M | −$24.6M | — | -2.72 | −$23.2M | $0 | −$23.2M | Feb 28 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $0 | — | −$326.2M | −$303.3M | — | -13.48 | −$249.1M | $56K | −$249.1M | — | — |
| FY2024 · to Dec 31 | $8.6M | — | −$200.2M | −$182.8M | -2137.5% | -10.21 | −$131.8M | $0 | −$131.8M | — | — |
| FY2023 · to Dec 31 | $2.4M | — | −$126.4M | −$123.3M | -5037.9% | -18.69 | −$111.1M | $50K | −$111.2M | — | — |
| FY2022 · to Dec 31 | $0 | — | −$215M | −$214M | — | -69.65 | −$185M | $444K | −$185.5M | — | — |
| FY2021 · to Dec 31 | — | — | −$167.3M | −$167.1M | — | -3.94 | −$124.6M | $1.1M | −$125.6M | — | — |
| FY2020 · to Dec 31 | — | — | −$62M | −$61.8M | — | -7.86 | −$52.6M | $0 | −$52.6M | — | — |
Every number comes from Praxis Precision Medicines, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.